Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Reservoirs”

140 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 140 results

Early research (Phase 1)Active Not RecruitingNCT05612178
What this trial is testing

Evaluate the Safety and Effects of Repeated Doses of 3BNC117-LS and 10-1074-LS on Persistent Viral Reservoirs in People Living With HIV and on Suppressive Antiretroviral Therapy

Who this might be right for
HIV-1
National Institute of Allergy and Infectious Diseases (NIAID) 105
Not applicableNot Yet RecruitingNCT05752318
What this trial is testing

Analysis of the Persistence, Reservoir and HIV Latency

Who this might be right for
HIV Infected IndividualsInformed Consent
University Hospital, Strasbourg, France 500
Early research (Phase 1)Looking for participantsNCT07481175
What this trial is testing

Inhibiting the Anti-apoptotic Factor, BCL-2, at the Time of ART Initiation to Promote Apoptosis of HIV-infected Cells and Restrict the Seeding of the HIV Reservoir (The INITIATE Study)

Who this might be right for
HIV-1
Thomas Aagaard Rasmussen 38
Testing effectiveness (Phase 2)Study completedNCT02440789
What this trial is testing

Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy (ART)

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 32
Not applicableStudy completedNCT00884793
What this trial is testing

Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the Gut

Who this might be right for
HIV Infections
University of California, San Francisco 8
Testing effectiveness (Phase 2)UnknownNCT00951743
What this trial is testing

Safety and Efficacy of ADAPTAVIR's Ability to Eliminate Treatment-Resistant Infectious Virus in Peripheral Blood Mononuclear Cells (PBMCs)

Who this might be right for
HIV Infections
Rapid Laboratories Inc. 40
Post-approval studies (Phase 4)UnknownNCT04295460
What this trial is testing

Triple vs. Double Therapy in naïves HIV-Infected Patients

Who this might be right for
HIV Infection
Hospitales Universitarios Virgen del Rocío 70
Large-scale testing (Phase 3)Study completedNCT00808002
What this trial is testing

Efficacy of Treatment Intensification With Maraviroc on HIV-1 Viral Latency in Recently Infected Hiv-1 naïve Patients Starting Raltegravir Plus Tenofovir/Emtricitabine

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 30
Not applicableStudy completedNCT01490346
What this trial is testing

Tissue Drug Levels of HIV Medications

Who this might be right for
Human Immunodeficiency Virus
University of Minnesota 22
Not applicableLooking for participantsNCT04174755
What this trial is testing

Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV

Who this might be right for
ObesityHIV-1-infection
University College Dublin 80
Testing effectiveness (Phase 2)Study completedNCT05004038
What this trial is testing

BCG Vaccination Effect on Latent Reservoir Size in Treated HIV-1 Infection:

Who this might be right for
HIV-1-infection
University of Zurich 60
Early research (Phase 1)Study completedNCT02269605
What this trial is testing

Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatment

Who this might be right for
HIV Infection
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 12
Not applicableUnknownNCT02557997
What this trial is testing

Effects of Dolutegravir Based Regimen on HIV-1 Reservoir and Immune Activation

Who this might be right for
HIV-1 Infection
University Hospital, Strasbourg, France 202
Testing effectiveness (Phase 2)Study completedNCT03262441
What this trial is testing

MMF for HIV Reservoir Reduction

Who this might be right for
Human Immunodeficiency Virus I Infection
Fred Hutchinson Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT00976404
What this trial is testing

Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir

Who this might be right for
HIV Infection
Robert L. Murphy 28
Early research (Phase 1)Study completedNCT02191098
What this trial is testing

Proof of Principle Study of Pulse Dosing of IL-15 to Deplete the Reservoir in HIV Infected People

Who this might be right for
HIVStable ART
University of Minnesota 10
Not applicableActive Not RecruitingNCT04888754
What this trial is testing

A Prospective Cohort for ex Vivo Cure Studies With Chronic HIV Infected Patients in the Netherlands

Who this might be right for
HIV InfectionsHIV-1-infectionHIV-2 Infection
Erasmus Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT00520897
What this trial is testing

Integrase Inhibitor (MK-0518) Viral Decay

Who this might be right for
HIV Infections
Canadian Immunodeficiency Research Collaborative 24
Not applicableStudy completedNCT06363500
What this trial is testing

Characterization of HIV-1 Reservoirs in HIV-1 Non-B Infected Adolescents on ART in Cameroon

Who this might be right for
Characterization of HIV Reservoirs in Adolescents
Chantal Biya International Reference Centre for Research on Prevention and Management of HIV/AIDS 140
Large-scale testing (Phase 3)UnknownNCT02219672
What this trial is testing

Study on the Impact of Triptolide Woldifiion on HIV-1 Reservoir In Acute HIV-1 Infection

Who this might be right for
AIDS/HIV PROBLEM
Peking Union Medical College 18
Next Page